title: New targets for cancer chemotherapy.
authors.affiliation: Investigational Drug Branch, Cancer Therapy Evaluation Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, 6130 Executive Blvd., Rockville, MD 20852, USA. murgoa@ctep.nci.nih.gov
authors.forename: Anthony J
authors.initials: AJ
authors.lastname: Murgo
authors.forename: Janet
authors.initials: J
authors.lastname: Dancey
authors.forename: S Gail
authors.initials: SG
authors.lastname: Eckhardt
authors.forename: Manuel
authors.initials: M
authors.lastname: Hidalgo
authors.forename: Susan G
authors.initials: SG
authors.lastname: Arbuck
authors.forename: Kenn
authors.initials: K
authors.lastname: Zerivitz
authors.forename: Barbara A
authors.initials: BA
authors.lastname: Blaylock
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D017209:Apoptosis / Q000187:drug effects; D002454:Cell Differentiation / Q000187:drug effects; D002986:Clinical Trials as Topic; D018432:Drug Resistance, Multiple; D019008:Drug Resistance, Neoplasm; D004791:Enzyme Inhibitors / Q000627:therapeutic use*; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D015398:Signal Transduction / Q000187:drug effects; D019098:Telomerase / Q000037:antagonists & inhibitors
chemical_list: D000970:Antineoplastic Agents; D004791:Enzyme Inhibitors; D019098:Telomerase